Bruce H. Littman

Mediqventures Ltd. provides financing services for life science technologies. The private company is based in Douglas, UK. The British company was founded by Gregory H. Bailey.

Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux.

Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom.

Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom.

Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA.

Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO.

Pfizer Europe International Ltd. is an Irish company.

Part of Pfizer Inc., Pfizer Japan, Inc. is a research and Japanese development pharmaceutical company founded in 1953. The company is based in Tokyo, Japan. The company's focus is on breakthroughs that greatly change patients' lives, contributing to the improvement of patients' health and life expectancy.

The Pulmonary Vascular Research Institute operates as a medical research charity. The non-profit company is based in Canterbury, UK.

Serina Therapeutics, Inc. is a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley in 2006 and is headquartered in Huntsville, AL.

Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. The company has deep relationships with Oxford University and is located on the Oxford Science Park. Celleron is focused on developing new and innovative therapies to treat cancer, with a particular emphasis on clinical development. The British company is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. Celleron's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company was founded in 2004 and is led by CEO Nick la Thangue.

iOX Therapeutics Ltd. provides cancer therapeutics services. The company was founded by Vincenzo Cerundolo in February 2015 and is headquartered in London, the United Kingdom.

Kleo Pharmaceuticals, Inc. is a biotechnology company, which engages in the development of biospecific compounds designed to emulate and enhance the activity of biologics. Its compounds are designed to direct the immune system to destroy cancerous or virally infected cells, and treatment of multiple myeloma and COVID-19. It offers Antibody Recruiting Molecules (ARMs),Synthetic Antibody Mimics (SyAMs), and Monoclonal Antibody Therapy Enhancers (MATEs) pipeline. The company was founded by David A. Spiegel and Roy Prieb in 2015 and is headquartered in New Haven, CT.

Causeway Therapeutics Ltd. operates as a biotechnology company. It develops drugs for the treatment for patients. The company was founded by Derek S. Gilchrist and Neal L. Millar and is headquartered in Glasgow, the United States.

BYOMass, Inc. provides investment holding services. The company is headquartered in Sudbury, MA.

Opsidio LLC engages in developing monoclonal antibodies to treat fibrotic and remodeling diseases. The company is headquartered in Bryn Mawr, PA.

Palantir Group, Inc. biotechnology merchant bank. The company is headquartered in Monkton, MD.

Public Ventures LLC is a registered broker-dealer headquartered in Dallas, Texas. The firm was founded by Christopher Marlett and Anthony DiGiandomenico in 1997. They are a wholly-owned subsidiary of MDB Capital Holdings LLC. Public Ventures offers Go-to-Market Strategy, Market Assessments, Revenue Generation and Product Strategy for technology companies that targets the Public Sector.

Part of Sabre Corp., PRISM Technologies LLC is a company that provides intellectual property licensing, and technology research and development services. The company is based in Omaha, NE. The company was founded by Gregory J. Duman. PRISM Technologies was acquired by Prism Technologies Group, Inc. on March 30, 2015 for $75.15 million.

Dura Medic LLC provides medical products. It supplies durable medical equipment specializing in cost elimination for hospitals and other healthcare providers. The company was founded by Gregory H. Bailey in 2004 and is headquartered in Austin, TX.

iWin, Inc. develops, publishes and distributes online games for mass market. It offers free, download, ad-supported and online multiplayer games in various categories, including hidden objects, time management, puzzles, logics, jigsaw, action, arcade, adventure, marble shooting, tycoon, card, board, game shows, steals and deals, online party and kids and cash games. The company was founded by Charles J. Wolf, Jr. and David Fox in August 2001 and is headquartered in San Francisco, CA.

Sentien Biotechnologies, Inc. develops cell-based therapy for critical care. It provides the Sentinel, a device that actively treats patients during a dialysis dose by supplementing patient blood with MSC-derived secretions. The company was founded by Brian Miller and Biju Parekkadan and is headquartered in Lexington, MA.

Propel LLC is a private company based in Des Moines, IA and has subsidiaries in the United States. Propel LLC offers fractional executive services with executive-level marketing. The company's fractional executives are experienced and have worked with top corporate brands and successful start-ups. Propel LLC provides diverse and proven subscription-based fractional executives to take businesses to new heights. The company offers fractional chief operating officer solutions to its leading network of fractional chief marketing officers. Propel LLC's rebrand reflects its tagline and motto: move forward today. The company was founded by Gregory H. Bailey, who has been the CEO since incorporation.